2022 Early Hearing Detection & Intervention Virtual Conference
March 13 - 15, 2022
4/15/2014 | 11:30 AM - 12:00 PM | Strategies for Early Congenital Cytomegalovirus Detection: Before and After the Utah HB81 Law | Grand Ballroom 1 | 9
Strategies for Early Congenital Cytomegalovirus Detection: Before and After the Utah HB81 Law
Cytomegalovirus (CMV), a member of the ?-herpesvirus family, is the most common infectious cause of congenital sensorineural hearing loss (SNHL). It is estimated that 40,000 congenitally infected neonates are born annually in the United States and may account for 20% or more of SNHL in young children. The recognition of this disease as a major public health problem in Utah was a major factor in the successful enactment of the CMV Public Health Initiative. The focus of this presentation will be to demonstrate the rationale for this initiative, and the achievements already obtained since implementation. We will present the challenges from a prior study attempting to screen all infants for CMV, preliminary data from the Utah CMV Public Health Initiative and our current approach to the child diagnosed with CMV induced SNHL.
- Identify the challenges in diagnosing a child with cytomegalovirus induced hearing loss
- Understand the advantages of diagnosing a child with cytomegalovirus induced hearing loss.
- Understand the achievements and limitations of the Utah Cytomegalovirus Public Health Initiative
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Albert Park
(Primary Presenter,Co-Presenter,Author), University of Utah, albert.park@hsc.utah.edu;
Albert Park, MD, serves as the section chief of pediatric otolaryngology and professor within the Department of Surgery and the Department of Pediatrics at the University of Utah. Dr. Park obtained his MD at the Washington University School of Medicine. He then completed his residency training at Loyola University Medical Center and pediatric otolaryngology fellowship training at the Hospital for Sick Children in Toronto, Canada. His primary research interest focuses on understanding the pathophysiology of congenital cytomegalovirus (CMV) induced hearing loss and developing novel assays for diagnosis.
ASHA DISCLOSURE:
Financial -
Nonfinancial -